Home > Insider Trading > Filing (0001209191-14-019571)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1593034	Endo International Plc	ENDP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1328288	P. Ivan Gergel	C/O Endo International Plc 25-28 North Wall Quay Dublin L2 1	Evp, R&D And Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2014-03-10	15,742	$20.61	43,391	No	4	M	Direct
Ordinary Shares	Disposition	2014-03-10	15,742	$72.47	27,649	No	4	S	Direct
Ordinary Shares	Acquisiton	2014-03-10	31,162	$33.98	58,811	No	4	M	Direct
Ordinary Shares	Disposition	2014-03-10	31,162	$72.47	27,649	No	4	S	Direct
Ordinary Shares	Acquisiton	2014-03-10	22,126	$34.70	49,775	No	4	M	Direct
Ordinary Shares	Disposition	2014-03-10	22,126	$72.47	27,649	No	4	S	Direct
Ordinary Shares	Acquisiton	2014-03-10	6,607	$30.80	34,256	No	4	M	Direct
Ordinary Shares	Disposition	2014-03-10	6,607	$72.47	27,649	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	2004 Stock Incentive Plan Stock Options (NQ)	Disposition	2014-03-10	15,742	$0.00	15,742	$20.61
Ordinary Shares	2010 Stock Incentive Plan Stock Options (NQ)	Disposition	2014-03-10	31,162	$0.00	31,162	$33.98
Ordinary Shares	2010 Stock Incentive Plan Stock Options (NQ)	Disposition	2014-03-10	22,126	$0.00	22,126	$34.70
Ordinary Shares	2010 Stock Incentive Plan Stock Options (NQ)	Disposition	2014-03-10	6,607	$0.00	6,607	$30.80

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2020-02-19	No	4	M	Direct
10,387	2021-02-23	No	4	M	Direct
22,124	2022-02-22	No	4	M	Direct
19,820	2023-02-27	No	4	M	Direct

Footnotes

This represents the price at which Dr. Gergel's ordinary shares were sold on March 10, 2014.
Dr. Gergel's stock options that were granted under the 2004 Stock Incentive Plan on February 19, 2010, were generally exercisable 25% per year on each of February 19, 2011, February 19, 2012, February 19, 2013 and February 19, 2014.
These securities were granted to Dr. Gergel in consideration of his services as Executive Vice President, Research & Development & Chief Scientific Officer of Endo Health Solutions Inc.
Dr. Gergel's stock options that were granted under the 2010 Stock Incentive Plan on February 23, 2011, were or are generally exercisable 25% per year on each of February 23, 2012, February 23, 2013, February 23, 2014 and February 23, 2015.
Dr. Gergel's stock options that were granted under the 2010 Stock Incentive Plan on February 22, 2012, were or are generally exercisable 25% per year on each of February 22, 2013, February 22, 2014, February 22, 2015 and February 22, 2016.
Dr. Gergel's stock options that were granted under the 2010 Stock Incentive Plan on February 27, 2013, were or are generally exercisable 25% per year on each of February 27, 2014, February 27, 2015, February 27, 2016 and February 27, 2017.